Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial–mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis
Crossref DOI link: https://doi.org/10.1007/s11010-016-2697-y
Published Online: 2016-03-31
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iskender, Banu
Izgi, Kenan
Canatan, Halit
Funding for this research was provided by:
The Scientific and Technological Research Council of Turkey (115S042, 114S542, 113S927)
Text and Data Mining valid from 2016-03-31